Holen Sie sich die Stockscreener-App
2.10
0.48%
0.01
Vorhandelsmarkt:
2.03
-0.07
-3.33%
Schlusskurs vom Vortag:
$2.09
Offen:
$2.1
24-Stunden-Volumen:
48,909
Relative Volume:
0.34
Marktkapitalisierung:
$36.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.48%
6M Leistung:
-23.64%
1J Leistung:
-45.74%
1-Tages-Spanne:
$2.09
$2.10
1-Wochen-Bereich:
$2.08
$2.10
52-Wochen-Spanne:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.10 | 36.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Citadel Group discloses 1.38% stake in Mural Oncology By Investing.com - Investing.com South Africa
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
What drives Mural Oncology plc stock priceLow Risk Investment Ideas & Rapid Capital Gain - earlytimes.in
Is Mural Oncology plc stock attractive for ETFsJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Mural Oncology plc stock remains a top recommendation - newser.com
Will Mural Oncology plc stock benefit from green energy trendsTrade Entry Report & Safe Capital Growth Plans - newser.com
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Citadel discloses 1.31% stake in Mural Oncology - Investing.com India
Citadel discloses 1.31% stake in Mural Oncology By Investing.com - Investing.com Canada
What candlestick patterns are forming on Mural Oncology plcJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Mural Oncology plc a candidate for recovery playJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Citadel Group discloses 1.3% stake in Mural Oncology By Investing.com - Investing.com South Africa
Citadel Group discloses 1.3% stake in Mural Oncology - Investing.com India
Why Mural Oncology plc stock is favored by pension fundsWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Citadel Group discloses 1.26% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.26% stake in Mural Oncology - Investing.com India
Is it too late to sell Mural Oncology plcPortfolio Profit Report & Community Supported Trade Ideas - newser.com
How Mural Oncology plc stock performs during Fed tightening cyclesPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Combining price and volume data for Mural Oncology plc - newser.com
Is Mural Oncology plc stock attractive for growth ETFsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Analysis and ForecastPrice Action Trading & Discover Top Gainers in Every Sector - earlytimes.in
What analysts say about Mural Oncology plc stockSector Rotation Strategies & Get The Analyst Consensus With One Click - earlytimes.in
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Mural Oncology Plc-Aktie (MURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):